Screener
Emergent Biosolutions EBS Q3 2025 earnings
Reported October 29, 2025 · After market close
Revenue$231.1MBeat by $13.6M
EPS$1.06Beat by $1.18
Revenue estimate$217.5M
EPS estimate-$0.12
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$123.2M
EPS estimate-$0.37
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Emergent Biosolutions report Q3 2025 earnings?
- Emergent Biosolutions (EBS) reported Q3 2025 earnings on October 29, 2025 after market close.
- What were Emergent Biosolutions's Q3 2025 revenue and EPS?
- Emergent Biosolutions reported revenue of $231.1M and eps of $1.06 for Q3 2025.
- Did Emergent Biosolutions beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $217.5M by $13.6M. EPS beat the consensus estimate of $-0.12 by $1.18.
- How did Emergent Biosolutions's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 21.3% from $293.8M a year earlier and eps declined 22.6% from $1.37.
- Where can I find Emergent Biosolutions's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001367644-25-000198) and the 10-Q periodic report (0001367644-25-000202) directly on SEC EDGAR. The filing index links above go to sec.gov.
